Frank Tarazi, MBBS, PhD, MBA is an Associate Professor of Psychiatry and Neuroscience at Harvard Medical School, and Director of Psychiatric Neuroscience Program at McLean Hospital. He received his medical degree from St. Joseph University, his doctorate degree in neuropsychiatry from Rutgers University and his Executive MBA degree from Northeastern University, USA. Dr. Tarazi published over 120 original articles and reviews in highly circulated scientific and medical journals. He also published over 10 book chapters, including a chapter in the standard textbook "Goodman and Gilman's The Pharmacological Basis of Therapeutics", and co-edited a book entitled " Neurological and Psychiatric Disorders: From Bench to Bedside". Dr. Tarazi is the Associate Editor of “Pharmacology and Therapeutics” and “CNS Spectrums” and serves on the editorial board of several other journals. His research focuses on better understanding the pathophysiology of neuropsychiatric disorders and their improved treatment. He has been awarded research funding from NIH, NARSAD, the Stanley Foundation, and from several pharmaceutical and biotechnology companies.
Dr. Tarazi received several awards, including the A.E. Bennett Award from the Society of Biological Psychiatry, the Rafaelsen Fellowship Award from the Collegium Internationale NeuroPsychopharmacologicum, the Jordi-Folch Pi Memorial Award from the American Society for Neurochemistry, the Alfred Pope Award from McLean Hospital, and the Dean's Dissertation Award from Rutgers University. He is a Fellow of the American College of Neuropsychopharmacology (ACNP), and a member of the American Psychiatric Association and the American Academy of Neurology. He also a member of the World Economic Forum’s Global Council on Neurotechnologies and Brain Research.